Noisy
← this week  ·  Subscribe →

The world is being quietly rearranged by people who write very long documents.

Federal Register · November 25, 2025
The title they went with Immunology and Microbiology Devices; Reclassification of Nucleic Acid-Based Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product; Proposed Amendment; Proposed Order; Request for Comments Noisy translates that to

Cancer drug tests can now get approved faster, with less paperwork

What happened
US health regulators want to move some cancer drug tests from the highest approval category to a lower one. This means these tests will need less rigorous review before they can be sold.
Why it matters
For years, all new high-risk medical devices, including many advanced cancer diagnostic tests, had to go through a long and expensive approval process. This change means that certain DNA-based tests used with specific cancer drugs can now get to market faster. It could speed up how quickly new personalized cancer treatments become available to patients.
The signal
Watch how quickly new DNA-based cancer tests are approved under these new rules, and whether the number of approved tests increases significantly in the next two years.
If you insist
Read the original →